Company: SXTPW
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001013762-25-003343
Chunk: 1185

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 4
Chunk 1185
---
 60P. In addition, he is the founder and Principal of Tax & Accounting Practice at Miller Tax &
Advisory since 2011. In that role, Mr. Miller advises owners of closely held businesses on accounting, financial and tax matters and
has designed accounting systems for private sector businesses. From 2002 to 2011, he was a Senior Accountant at Sachs Figurelli, LLC,
where he prepared and processed corporate and individual tax returns, consulted on reengineering accounting processes for construction,
restaurant and professional services businesses and managed staff in preparation and processing of payroll and personal property returns.
Mr. Miller is currently a Certified Public Accountant. He received a Bachelor’s of Business Administration with a concentration
in International Business from Emory University in 1996.

Kristen Landon is our Chief Commercial
Officer. Ms. Landon joined us in 2024 and brings over 26 years’ experience building and transforming pharmaceutical brands in both
start-up and large multinational companies. Ms. Landon has launched and relaunched over a dozen brands, many with peak revenues in excess
of $100 million across therapeutic categories including women’s health, infectious disease, dermatology, nephrology, and hematology/oncology.
Most recently, Ms. Landon served as Senior Vice President of Marketing and Communications at TherapeuticsMD with responsibility for the
branded portfolio, marketing insights, and corporate communications. Prior commercial leadership roles include VP Marketing at Radius
Health, VP Marketing at Sprout Pharmaceuticals (acquired by Valeant), Executive Director Women’s Health at Actavis Plc, and positions
of increasing responsibility in sales and marketing at Forest Labs, Abbott Labs, and Novartis. Ms. Landon holds an MBA from Silberman
College of Business at Fairleigh Dickinson University, and a Bachelor’s degree from Kean University.

61

Charles Allen is one of our directors
since July 11, 2023 and since February 5, 2014 has served as the Chief Executive Officer of BTCS Inc. (“BTCS”) and the Chairman
of the Board of BTCS since September 11, 2014. Mr. Allen is responsible for BTCS’ overall corporate strategy and direction. Since
December 2, 2022, Mr. Allen has been a director of Innovation1 Biotech Inc. Since January 12, 2018, Mr. Allen has been the Chief Executive
Officer of Global Bit Ventures Inc. (“GBV”). Since October 10